Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-19

Clinical Trial Update: A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the efficacy and safety of 20% Cassia alata extract for treating Tinea versicolor; the study is currently recruiting at The Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 20% Cassia alata extract (Cassia alata extract)

Snippet

Sponsor: The University of The West Indies | Conditions: Tinea Versicolor, Pityriasis Versicolor | Phase 1 | Status: RECRUITING